AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Ultralife Corporation

$5.56 -$0.09 (-1.59%)
NASDAQ · 14 Sep 2026 20:00 UTC
Previous Close
$5.6
Day Range
$5.43$5.74
Year Range
$4.9$8.25
Market Cap
92.61M
AVG Volume
43.98K
Trailing/Forward PE
-13.89/6.47
PEG ratio
-0.61
Dividend Yield
-
Next Earnings Date
2026-11-09
Primary Exchange
NASDAQUS
Revenue (USD)
050M100M150M200M2016201720182019202020212022202320242025
ULBI Revenue (USD) by year
PeriodRevenue (USD)
2025191.16M
2024164.46M
2023158.64M
2022131.84M
202198.27M
2020107.71M
2019106.8M
201887.19M
201785.53M
201682.46M
Net Income (USD)
-10M010M20M30M2016201720182019202020212022202320242025
ULBI Net Income (USD) by year
PeriodNet Income (USD)
2025-5.9M
20246.31M
20237.2M
2022-119K
2021-234K
20205.23M
20195.21M
201824.93M
20177.65M
20163.51M
Operating Income (USD)
02.5M5M7.5M10M2016201720182019202020212022202320242025
ULBI Operating Income (USD) by year
PeriodOperating Income (USD)
20257.47M
20249.96M
20239.47M
2022129K
202135K
20205.7M
20197.37M
20186.55M
20176.48M
20163.76M
EBITDA (USD)
05M10M15M20M2016201720182019202020212022202320242025
ULBI EBITDA (USD) by year
PeriodEBITDA (USD)
20251.05M
202414.4M
202315.04M
20224.96M
20213.63M
20208.66M
201910.17M
20188.96M
20178.85M
20166.8M
Cash Flows (USD)
-10M010M20M2016201720182019202020212022202320242025
ULBI Cash Flows (USD) by year
PeriodCash Flows (USD)
20257.12M
202414.77M
2023-623K
2022-2.94M
20211.51M
202018.62M
2019-9.25M
20186.7M
20175.88M
20166.43M
EPS (USD)
-0.500.511.522016201720182019202020212022202320242025
ULBI EPS (USD) by year
PeriodEPS (USD)
2025-0.36
20240.39
20230.44
2022-0.01
2021-0.02
20200.33
20190.33
20181.53
20170.49
20160.23
Expenses (USD)
020M40M60MR&DSG&ACapex2016201720182019202020212022202320242025
ULBI Expenses (USD) by year
PeriodExpenses (USD)
202540.91M
202434.28M
202332.28M
202230.95M
202127.42M
202026.56M
201930.08M
201823.02M
201720.96M
201622.31M
Cash & Debt (USD)
020M40M60MCashLong Term DebtShort Term Debt2016201720182019202020212022202320242025
ULBI Cash & Debt (USD) by year
PeriodCash & Debt (USD)
20259.35M
20246.85M
202310.28M
20225.71M
20218.41M
202010.65M
20197.41M
201825.93M
201718.33M
201610.71M
Debt ratios
-101220182019202020212022202320242025
ULBI Debt ratios by year
PeriodDebt ratios
20251.14
20241.35
20230.58
20220.65
20210.48
2020-0.19
20190.33
2018-0.85
Margins
0%10%20%30%40%2016201720182019202020212022202320242025
ULBI Margins by year
PeriodMargins
202523.28%
202425.73%
202324.71%
202222.3%
202125.08%
202027.07%
201929.18%
201829.34%
201730.67%
201630.45%
Return on Capital
-10%0%10%20%30%2016201720182019202020212022202320242025
ULBI Return on Capital by year
PeriodReturn on Capital
2025-4.53%
20244.7%
20235.74%
2022-0.1%
2021-0.2%
20204.47%
20194.74%
201823.85%
20179.67%
20165.17%
Shares Outstanding
05M10M15M20M2016201720182019202020212022202320242025
ULBI Shares Outstanding by year
PeriodShares Outstanding
202516.65M
202416.63M
202316.34M
202216.14M
202116.06M
202015.94M
201915.86M
201815.95M
201715.63M
201615.26M
Book Value Per Share (USD)
02.557.5102016201720182019202020212022202320242025
ULBI Book Value Per Share (USD) by year
PeriodBook Value Per Share (USD)
20257.81
20248.07
20237.68
20227.21
20217.33
20207.34
20196.92
20186.55
20175.06
20164.45
Total Assets (USD)
0100M200M300M2016201720182019202020212022202320242025
ULBI Total Assets (USD) by year
PeriodTotal Assets (USD)
2025216.91M
2024220.45M
2023178.28M
2022168.43M
2021159.54M
2020137.7M
2019144.56M
2018120.1M
201797.19M
201684.74M
Employee Count
02004006008002016201720182019202020212022202320242025
ULBI Employee Count by year
PeriodEmployee Count
2025678
2024671
2023536
2022547
2021560
2020532
2019573
2018580
2017568
2016552
PE Ratio
020406080med 17.85Jun 24Oct 24Jan 25May 25Aug 25Dec 25Mar 26
ULBI PE Ratio by year
PeriodPE Ratio
Mar 2662.3
Mar 2663.46
Mar 2650.87
Feb 2654.94
Feb 2656.88
Feb 2662.2
Feb 2661.43
Jan 2661.82
Jan 2661.82
Jan 2664.24
Jan 2656.97
Jan 2654.74
Dec 2555.81
Dec 2555.62
Dec 2555.71
Dec 2554.74
Nov 2555.13
Nov 2550.77
Nov 2528.94
Nov 2535.13
Oct 2536.59
Oct 2536.17
Oct 2533.52
Oct 2533.36
Oct 2535.76
Sep 2535.45
Sep 2536.75
Sep 2535.65
Sep 2537.06
Aug 2536.17
Aug 2537.53
Aug 2533.88
Aug 2534.3
Aug 2524.32
Jul 2527.12
Jul 2527.34
Jul 2527.12
Jul 2528.54
Jun 2525.49
Jun 2525.58
Jun 2524.35
Jun 2524.23
May 2520.99
May 2517.18
May 2518.03
May 2513.3
May 2511.59
Apr 2512.09
Apr 2511.28
Apr 2512.43
Apr 2511.91
Mar 2510.1
Mar 2510.11
Mar 2510.21
Mar 2511.21
Feb 2511.59
Feb 2512.31
Feb 2513.24
Feb 2513.78
Jan 2514.02
Jan 2514.83
Jan 2514.46
Jan 2513.65
Jan 2514.07
Dec 2413.48
Dec 2413.48
Dec 2414.37
Dec 2414.02
Nov 2414.18
Nov 2414.11
Nov 2413.61
Nov 2413.14
Nov 2414.08
Oct 2414.52
Oct 2414.98
Oct 2415.08
Oct 2415.82
Sep 2414.9
Sep 2415.25
Sep 2415.72
Sep 2415.2
Aug 2417.22
Aug 2418.39
Aug 2417.07
Aug 2416.61
Aug 2417.8
Jul 2418.14
Jul 2417.19
Jul 2417.46
Jul 2416.03
Jun 2416.69
Jun 2415.71
Jun 2415.93
Jun 2417.13
May 2418.29
May 2417.76
May 2417.68
May 2419.38
May 2419.72
Apr 2417.9
Free Cash Flow Yield
0%5%10%15%20%25%med 10.67%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
ULBI Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 262.19%
Sep 262.18%
Sep 261.99%
Aug 261.88%
Aug 261.74%
Aug 261.62%
Aug 261.92%
Jul 267.09%
Jul 266.94%
Jul 266.68%
Jul 266.29%
Jul 266.01%
Jun 265.95%
Jun 265.7%
Jun 265.59%
Jun 265.5%
May 265.08%
May 265.72%
May 266.06%
May 266.17%
May 266.23%
Apr 265.66%
Apr 265.52%
Apr 266.29%
Apr 266.4%
Mar 266.7%
Mar 268.43%
Mar 268.27%
Mar 2610.32%
Feb 269.56%
Feb 269.23%
Feb 268.44%
Feb 268.55%
Jan 268.49%
Jan 268.49%
Jan 268.17%
Jan 269.21%
Jan 269.59%
Dec 259.41%
Dec 259.44%
Dec 259.42%
Dec 259.59%
Nov 259.52%
Nov 2510.34%
Nov 2515.1%
Nov 2512.44%
Oct 2511.94%
Oct 2512.08%
Oct 2513.04%
Oct 2513.1%
Oct 2512.22%
Sep 2512.33%
Sep 2511.89%
Sep 2512.26%
Sep 2511.79%
Aug 2512.08%
Aug 2511.65%
Aug 2512.9%
Aug 2512.74%
Aug 2513.76%
Jul 2512.34%
Jul 2512.24%
Jul 2512.34%
Jul 2511.73%
Jun 2513.14%
Jun 2513.09%
Jun 2513.75%
Jun 2513.82%
May 2515.95%
May 2519.49%
May 2518.57%
May 2517.59%
May 2520.19%
Apr 2519.35%
Apr 2520.76%
Apr 2518.82%
Apr 2519.65%
Mar 2515.08%
Mar 2515.06%
Mar 2514.92%
Mar 2513.59%
Feb 2513.13%
Feb 2512.37%
Feb 2511.5%
Feb 2511.05%
Jan 2510.86%
Jan 2510.27%
Jan 2510.53%
Jan 2511.16%
Jan 2510.82%
Dec 2411.3%
Dec 2411.3%
Dec 2410.6%
Dec 2410.86%
Nov 2410.74%
Nov 2410.79%
Nov 2411.19%
Nov 246.14%
Nov 245.73%
Oct 245.55%
Price to Sales
0.40.60.81med 0.59Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
ULBI Price to Sales by year
PeriodPrice to Sales
Sep 260.49
Sep 260.5
Sep 260.55
Aug 260.58
Aug 260.62
Aug 260.67
Aug 260.56
Jul 260.46
Jul 260.47
Jul 260.49
Jul 260.52
Jul 260.54
Jun 260.55
Jun 260.57
Jun 260.58
Jun 260.59
May 260.64
May 260.57
May 260.54
May 260.53
May 260.6
Apr 260.66
Apr 260.67
Apr 260.59
Apr 260.58
Mar 260.56
Mar 260.57
Mar 260.58
Mar 260.47
Feb 260.51
Feb 260.52
Feb 260.57
Feb 260.57
Jan 260.57
Jan 260.57
Jan 260.59
Jan 260.52
Jan 260.5
Dec 250.51
Dec 250.51
Dec 250.51
Dec 250.5
Nov 250.51
Nov 250.47
Nov 250.52
Nov 250.63
Oct 250.65
Oct 250.65
Oct 250.6
Oct 250.6
Oct 250.64
Sep 250.63
Sep 250.66
Sep 250.64
Sep 250.66
Aug 250.65
Aug 250.67
Aug 250.61
Aug 250.61
Aug 250.74
Jul 250.83
Jul 250.83
Jul 250.83
Jul 250.87
Jun 250.78
Jun 250.78
Jun 250.74
Jun 250.74
May 250.64
May 250.52
May 250.55
May 250.51
May 250.44
Apr 250.46
Apr 250.43
Apr 250.48
Apr 250.46
Mar 250.55
Mar 250.55
Mar 250.56
Mar 250.61
Feb 250.63
Feb 250.67
Feb 250.72
Feb 250.75
Jan 250.76
Jan 250.81
Jan 250.79
Jan 250.74
Jan 250.77
Dec 240.73
Dec 240.73
Dec 240.78
Dec 240.76
Nov 240.77
Nov 240.77
Nov 240.74
Nov 240.78
Nov 240.84
Oct 240.86
EV/EBITDA
050100150200med 10.54Aug 24Nov 24Mar 25Jun 25Oct 25Jan 26May 26
ULBI EV/EBITDA by year
PeriodEV/EBITDA
May 26146.63
Apr 26157.54
Apr 26160.54
Apr 26145.69
Apr 26143.79
Mar 26139.05
Mar 2613.16
Mar 2613.33
Mar 2611.45
Feb 2612.06
Feb 2612.35
Feb 2613.14
Feb 2613.03
Jan 2613.09
Jan 2613.09
Jan 2613.45
Jan 2612.36
Jan 2612.03
Dec 2512.19
Dec 2512.16
Dec 2512.18
Dec 2512.03
Nov 2512.09
Nov 2511.44
Nov 2511.01
Nov 2512.6
Oct 2512.98
Oct 2512.87
Oct 2512.19
Oct 2512.15
Oct 2512.77
Sep 2512.69
Sep 2513.02
Sep 2512.74
Sep 2513.1
Aug 2512.87
Aug 2513.22
Aug 2512.28
Aug 2512.39
Aug 2512.55
Jul 2513.59
Jul 2513.68
Jul 2513.59
Jul 2514.12
Jun 2512.98
Jun 2513.02
Jun 2512.56
Jun 2512.51
May 2511.3
May 259.88
May 2510.19
May 259.41
May 258.66
Apr 258.88
Apr 258.52
Apr 259.03
Apr 258.8
Mar 255.81
Mar 255.82
Mar 255.87
Mar 256.41
Feb 256.62
Feb 257.01
Feb 257.52
Feb 257.81
Jan 257.94
Jan 258.38
Jan 258.18
Jan 257.74
Jan 257.97
Dec 247.65
Dec 247.65
Dec 248.13
Dec 247.94
Nov 248.03
Nov 247.99
Nov 247.72
Nov 247.73
Nov 248.25
Oct 248.49
Oct 248.74
Oct 248.8
Oct 249.2
Sep 248.7
Sep 248.89
Sep 249.15
Sep 248.86
Aug 249.97
Aug 2410.61
Aug 249.89
Aug 249.64
Aug 2410.29
Jul 2410.48
Jul 2410.28
Jul 2410.43
Jul 249.65
Jun 2410.01
Jun 249.48
Jun 249.6
Jun 2410.25
Price/Operating Cashflow
0102030med 7.59Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
ULBI Price/Operating Cashflow by year
PeriodPrice/Operating Cashflow
Sep 2618.05
Sep 2618.18
Sep 2619.9
Aug 2621.01
Aug 2622.76
Aug 2624.38
Aug 2620.62
Jul 268.75
Jul 268.94
Jul 269.29
Jul 269.86
Jul 2610.32
Jun 2610.44
Jun 2610.89
Jun 2611.1
Jun 2611.28
May 2612.23
May 2610.86
May 2610.24
May 2610.07
May 2610.4
Apr 2611.44
Apr 2611.73
Apr 2610.3
Apr 2610.12
Mar 269.67
Mar 268.48
Mar 268.64
Mar 266.93
Feb 267.48
Feb 267.75
Feb 268.47
Feb 268.37
Jan 268.42
Jan 268.42
Jan 268.75
Jan 267.76
Jan 267.46
Dec 257.6
Dec 257.57
Dec 257.59
Dec 257.46
Nov 257.51
Nov 256.91
Nov 255.39
Nov 256.54
Oct 256.81
Oct 256.74
Oct 256.24
Oct 256.21
Oct 256.66
Sep 256.6
Sep 256.84
Sep 256.64
Sep 256.9
Aug 256.74
Aug 256.99
Aug 256.31
Aug 256.39
Aug 256.38
Jul 257.11
Jul 257.17
Jul 257.11
Jul 257.49
Jun 256.69
Jun 256.71
Jun 256.39
Jun 256.36
May 255.5
May 254.51
May 254.73
May 255.03
May 254.38
Apr 254.57
Apr 254.26
Apr 254.7
Apr 254.5
Mar 255.67
Mar 255.68
Mar 255.73
Mar 256.29
Feb 256.51
Feb 256.91
Feb 257.43
Feb 257.73
Jan 257.87
Jan 258.32
Jan 258.11
Jan 257.66
Jan 257.9
Dec 247.56
Dec 247.56
Dec 248.06
Dec 247.87
Nov 247.96
Nov 247.92
Nov 247.64
Nov 2412.73
Nov 2413.64
Oct 2414.07
Price to Book
0.40.60.811.2med 0.81Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
ULBI Price to Book by year
PeriodPrice to Book
Sep 260.7
Sep 260.7
Sep 260.77
Aug 260.81
Aug 260.88
Aug 260.94
Aug 260.8
Jul 260.67
Jul 260.68
Jul 260.71
Jul 260.75
Jul 260.79
Jun 260.79
Jun 260.83
Jun 260.84
Jun 260.86
May 260.93
May 260.83
May 260.78
May 260.77
May 260.88
Apr 260.97
Apr 260.99
Apr 260.87
Apr 260.85
Mar 260.82
Mar 260.78
Mar 260.79
Mar 260.64
Feb 260.69
Feb 260.71
Feb 260.78
Feb 260.77
Jan 260.77
Jan 260.77
Jan 260.8
Jan 260.71
Jan 260.68
Dec 250.7
Dec 250.7
Dec 250.7
Dec 250.68
Nov 250.69
Nov 250.63
Nov 250.67
Nov 250.81
Oct 250.84
Oct 250.83
Oct 250.77
Oct 250.77
Oct 250.82
Sep 250.82
Sep 250.85
Sep 250.82
Sep 250.85
Aug 250.83
Aug 250.87
Aug 250.78
Aug 250.79
Aug 250.94
Jul 251.05
Jul 251.06
Jul 251.05
Jul 251.1
Jun 250.99
Jun 250.99
Jun 250.94
Jun 250.94
May 250.81
May 250.66
May 250.7
May 250.63
May 250.55
Apr 250.57
Apr 250.53
Apr 250.58
Apr 250.56
Mar 250.67
Mar 250.68
Mar 250.68
Mar 250.75
Feb 250.77
Feb 250.82
Feb 250.88
Feb 250.92
Jan 250.94
Jan 250.99
Jan 250.97
Jan 250.91
Jan 250.94
Dec 240.9
Dec 240.9
Dec 240.96
Dec 240.94
Nov 240.95
Nov 240.94
Nov 240.91
Nov 240.99
Nov 241.06
Oct 241.1
Ultralife Corporation
ULBI
Stockpicker

Video analysis: ULBI

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: ULBI

Ultralife Stock Gains Post Q2 Earnings Despite Y/Y Revenue Dip

zacks.com · 12 Aug 2026

Ultralife Stock Gains Post Q2 Earnings Despite Y/Y Revenue Dip

ULBI's earnings improve in second-quarter 2026 despite softer revenues, as stronger margins, record backlog and operational gains supported its profitable-growth outlook.

Ultralife Q2 Earnings Call Highlights

marketbeat.com · 7 Aug 2026

Ultralife Q2 Earnings Call Highlights

Ultralife NASDAQ: ULBI reported second-quarter 2026 revenue of $47.9 million, operating income of $3.4 million and diluted earnings per share of $0.15, as the company cited stronger gross margins, a record backlog and continued investment in product development across its battery and communications businesses.

Ultralife Corporation (ULBI) Q2 2026 Earnings Call Transcript

seekingalpha.com · 7 Aug 2026

Ultralife Corporation (ULBI) Q2 2026 Earnings Call Transcript

Ultralife Corporation (ULBI) Q2 2026 Earnings Call Transcript

Ultralife Corporation Reports Second Quarter Results

globenewswire.com · 7 Aug 2026

Ultralife Corporation Reports Second Quarter Results

NEWARK, N.Y., Aug. 07, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the second quarter ended June 30, 2026 with the following results: Sales of $47.9 million compared to $48.6 million for the 2025 second quarter Gross profit of $13.9 million, or 28.9% of revenue, compared to $11.6 million, or 23.9% of revenue, for the 2025 second quarter; excluding a $1.1 million net IEEPA refund received in the 2026 second quarter, gross margin was 26.6% Operating income of $3.4 million, including one-time costs of $0.9 million, compared to $2.3 million including one-time costs of $0.3 million for the 2025 second quarter GAAP EPS of $0.15 compared to $0.05 for the 2025 second quarter Adjusted EBITDA of $6.1 million compared to $4.1 million for the 2025 second quarter Backlog of $117.5 million compared to $115.1 million exiting the first quarter of 2026 “For the second quarter we delivered a 760-basis point improvement in gross profit margin compared to the first quarter, including the contribution of the net IEEPA refund.

Ultralife Corporation to Report Second Quarter Results on August 7, 2026

globenewswire.com · 30 Jul 2026

Ultralife Corporation to Report Second Quarter Results on August 7, 2026

NEWARK, N.Y., July 30, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its second quarter results for the period ended June 30, 2026, before the market opens on Friday, August 7, 2026.

Zacks Initiates Coverage of Ultralife With Underperform Recommendation

zacks.com · 16 Jul 2026

Zacks Initiates Coverage of Ultralife With Underperform Recommendation

Discover why Zacks rates Ultralife as "Underperform", being the first on Wall Street to initiate coverage on the stock. Explore ULBI's struggles with execution risks, margin pressure and commercialization delays that could delay its earnings recovery.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.